Author Credentials

Farley B. Neasman III, MD




Heart failure is a growing epidemic that will add significant monetary and human costs to an already overtaxed health-care system. Though promising new medications have recently been approved, this complex condition is largely preventable through aggressive risk factor modification, with diet being shown to have a greater effect than exercise. An underrated component of a healthy diet is the simple addition of nuts – the anti-inflammatory fatty acids, healthy proteins, and general availability have been shown to improve survival and reduce the primary risk factors contributing to heart failure, making the addition of nuts and legumes to the diet an attractive, cost-effective tool to promote cardiovascular well-being.

Conflict(s) of Interest


References with DOI

1. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62(16):e147-e239. doi:10.1016/j.jacc.2013.05.019.

2. Azad N, Lemay G. Management of chronic heart failure in the older population. Journal of Geriatric Cardiology. 11.4 (2014): 329.

3. Roger VL. Epidemiology of heart failure. Circulation Research. 113.6 (2013): 646-659. https://doi.org/10.1161/circresaha.113.300268

4. http://news.heart.org/heart-failure-numbers-to-increase-by-nearly-40-percent-in-next-15-years/

5. Mozzafarian D, Benjamin EJ, Go AS, et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.

6. Curtis LH, Whellan DJ, Hammill BG, Hernandez AF, Anstrom KJ, Shea AM, Schulman KA. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Archives of Internal Medicine. 168.4 (2008): 418-424. https://doi.org/10.1001/archinternmed.2007.80

7. Hardy DR. The booming dynamics of aging: From awareness to action. Report of the 2005 White House Conference on Aging. 2005.

8. www.cms.gov

9. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44. https://doi.org/10.1161/cir.0b013e31820a55f5

10. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the united states a policy statement from the American Heart Association. Circulation: Heart Failure. 6.3 (2013): 606-619. https://doi.org/10.1161/hhf.0b013e318291329a

11. Kannel WB, Belanger AJ. Epidemiology of heart failure. American Heart Journal. 121.3 (1991): 951-957.

12. He J, Ogden LG, Bazzano lA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of Internal Medicine.161.7 (2001): 996-1002. https://doi.org/10.1001/archinte.161.7.996

13. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Annals of Internal Medicine.74.1 (1971): 1-12. https://doi.org/10.7326/0003-4819-74-1-1

14. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology. 62.4 (2013): 263-271.

15. Yancy, Clyde W., et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology. (2016). https://doi.org/10.1161/cir.0000000000000435

16. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 311.5 (2014): 507-520. https://doi.org/10.1001/jama.2013.284427

17. http://www.idf.org/treatment-algorithm-people-type-2-diabetes

18. Jensen, Michael D., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American College of Cardiology. 63.25_PA (2014). https://doi.org/10.1161/01.cir.0000437739.71477.ee

19. Panel, National Cholesterol Education Program NCEP Expert. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 106.25 (2002): 3143.

20. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation. 106.20 (2002): 2530-2532. https://doi.org/10.1097/00005768-200205001-00059

21. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Archives of Internal Medicine. 159.3 (1999): 285-293. https://doi.org/10.1001/archinte.159.3.285

22. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, JiangXG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise inpreventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 20.4 (1997): 537-544. https://doi.org/10.2337/diacare.20.4.537

23. Eriksson KF, Lindgärde F. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia. 34.12 (1991): 891-898. https://doi.org/10.1007/bf00400196

24. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Medicine and science in sports and exercise. 33.6; SUPP (2001): S502-S515. https://doi.org/10.1097/00005768-200106001-00021

25. Kelley GA, Kelley KS. Effects of diet, aerobic exercise, or both on non-HDL-C in adults: a meta-analysis of randomized controlled trials. Cholesterol. 2012 (2012). https://doi.org/10.1155/2012/840935

26. Rathore SS, Masoudi FA, Wang Y, Curtis JP, Foody JM, Havranek EP, Krumholz HM. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. American Heart Journal. 152.2 (2006): 371-378. https://doi.org/10.1016/j.ahj.2005.12.002

27. US Department of Health and Human Services, and US Department of Health and Human Services. Physical activity guidelines for Americans. (2008).

28. Eckel RH, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 63.25_PA (2014). https://doi.org/10.1161/01.cir.0000437740.48606.d1

29. Ward BW, et al. Early release of selected estimates based on data from the January–March 2013 National Health Interview Survey. National Center for Health Statistics (2013).

30. CDC.gov. Health, United States, 2015, table 53.

31. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. Jama. 311.8 (2014): 806-814. https://doi.org/10.1097/01.sa.0000451505.72517.a5

32. Miller WC, Koceja DM, Hamilton EJ. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. International Journal of Obesity. 21.10 (1997): 941-947. https://doi.org/10.1038/sj.ijo.0800499

33. Halton TL, Willett WC, Liu S, Manson JE, Stampfer MJ, Hu FB. Potato and french fry consumption and risk of type 2 diabetes in women. The American Journal of Clinical Nutrition. 83.2 (2006): 284-290.

34. Carrera-Bastos P, Fontes-Villalba M, O’Keefe JH, Lindeberg S, Cordain L. The western diet and lifestyle and diseases of civilization. Research Reports in Clinical Cardiology. 2 (2011): 15-35. https://doi.org/10.2147/rrcc.s16919

35. Galland L. Diet and inflammation. Nutrition in Clinical Practice. 25.6 (2010): 634-640.

36. Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE, Hu FB. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. The American Journal of Clinical Nutrition. 80.4 (2004): 1029-1035.

37. https://www.nhlbi.nih.gov/health/health-topics/topics/dash

38. Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases—incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition. 29.4 (2013): 611-618. https://doi.org/10.1016/j.nut.2012.12.018

39. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. Journal of the American College of Cardiology. 57.11 (2011): 1299-1313. https://doi.org/10.1016/j.jacc.2010.09.073

40. Sofi F, et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 337 (2008): a1344. https://doi.org/10.1136/bmj.a1344

41. Schwingshackl L, Missbach B, Konig J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutrition. 18.07 (2015): 1292-1299. https://doi.org/10.1017/s1368980014001542

42. Craig WJ, Mangels AR. Position of the American Dietetic Association: vegetarian diets. Journal of the American Dietetic Association 109.7 (2009): 1266-1282. https://doi.org/10.1016/j.jada.2009.05.027

43. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. The Lancet. 336.8708 (1990): 129-133. https://doi.org/10.1017/cbo9780511759048.038

44. Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD? Journal of Family Practice. 63.7 (2014): 356-364.

45. Sacks FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. New England Journal of Medicine 292.22 (1975): 1148-1151. https://doi.org/10.1056/nejm197505292922203

46. Fisher M, Levine PH, Weiner B, Ockene IS, Johnson B, Johnson MH, Natale AM, Vaudreuil CH, Hoogasian J. The effect of vegetarian diets on plasma lipid and platelet levels. Archives of Internal Medicine. 146.6 (1986): 1193-1197. https://doi.org/10.1001/archinte.146.6.1193

47. Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, et al. Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. The American Journal of Clinical Nutrition. 70.3 (1999): 516s-524s.

48. Clarke R, Shipley M, Armitage J, Collins R, Harris W. Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants. British Journal of Nutrition. 102.2 (2009): 279. https://doi.org/10.1017/s0007114508143562

49. Lennie TA, et al. Dietary fat intake and proinflammatory cytokine levels in patients with heart failure. Journal of Cardiac Failure. 11.8 (2005): 613-618. https://doi.org/10.1016/j.cardfail.2005.06.434

50. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans fatty acids and systemic inflammation in women. The American Journal of Clinical Nutrition. 79.4 (2004): 606-612.

51. Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. European Journal of Clinical Nutrition. 63 (2009): S5-S21. https://doi.org/10.1038/sj.ejcn.1602973

52. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic Association. 109.4 (2009): 668-679. https://doi.org/10.1016/j.jada.2008.12.022

53. Micallef MA, Munro IA, Garg ML. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. European Journal of Clinical Nutrition. 63.9 (2009): 1154-1156. https://doi.org/10.1038/ejcn.2009.20

54. Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis. 205.2 (2009): 538-543. https://doi.org/10.1016/j.atherosclerosis.2008.12.013

55. Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, Maiorino M, Ursini F. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arteriosclerosis, Thrombosis, and Vascular Biology. 12.4 (1992): 529-533. https://doi.org/10.1161/01.atv.12.4.529

56. Cholesterol, Beyond. Modifications of low-density lipoprotein that increase its atherogenicity Steinberg. 915-24.

57. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease. New England Journal of Medicine 353.1 (2005): 46-57.

58. Tsutsui T, et al. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. Journal of the American College of Cardiology. 39.6 (2002): 957-962. https://doi.org/10.1016/s0735-1097(02)01721-7

59. Sabaté J, Ang Y. Nuts and health outcomes: new epidemiologic evidence. The American Journal of Clinical Nutrition 89.5 (2009): 1643S-1648S. https://doi.org/10.3945/ajcn.2009.26736q

60. Bes-Rastrollo M, Wedick NM, Martinez-Gonzalez MA, Li TY, Sampson L, Hu FB. Prospective study of nut consumption, long-term weight change, and obesity risk in women. The American Journal of Clinical Nutrition. 89.6 (2009): 1913-1919. https://doi.org/10.3945/ajcn.2008.27276

61. Martínez-González MA, Bes-Rastrollo M. Nut consumption, weight gain and obesity: Epidemiological evidence. Nutrition, Metabolism and Cardiovascular Diseases 21 (2011): S40-S45. https://doi.org/10.1016/j.numecd.2010.11.005

62. Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E, Deulofeu R. A walnut diet improves endothelial function in hypercholesterolemic subjects a randomized crossover trial. Circulation. 109.13 (2004): 1609-1614. https://doi.org/10.1016/j.accreview.2004.06.062

63. Ma Y, Njike VY, Millet J, Dutta S, Doughty K, Treu JA, Katz DL. Effects of Walnut Consumption on Endothelial Function in Type 2 Diabetic Subjects: A randomized controlled crossover trial. Diabetes Care 33.2 (2010): 227-232. https://doi.org/10.2337/dc09-1156

64. Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. The American Journal of Clinical Nutrition 78.3 (2003): 544S-551S.

65. Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H, Ozer O, Aksoy N, Aksoy M. Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition. 26.4 (2010): 399-404. https://doi.org/10.1016/j.nut.2009.05.023

66. Spiller GA, Jenkins DJ, Cragen LN, Gates JE, Bosello O, Berra K, Rudd C, Stevenson M, Superko R. Effect of a diet high in monounsaturated fat from almonds on plasma cholesterol and lipoproteins. Journal of the American College of Nutrition. 11.2 (1992): 126-130.

67. Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. The American Journal of Clinical Nutrition. 59.5 (1994): 995-999.

68. Mukuddem-Petersen J, Oosthuizen W, Jerling JC. A systematic review of the effects of nuts on blood lipid profiles in humans. The Journal of Nutrition. 135.9 (2005): 2082-2089.

69. Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarty K, Fishell V, Etherton TD. High– monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. The American Journal of Clinical Nutrition . 70.6 (1999): 1009-1015.

70. Kelly JH, Sabaté J. Nuts and coronary heart disease: an epidemiological perspective. British Journal of Nutrition. 96.S2 (2006): S61-S67. https://doi.org/10.1017/bjn20061865

71. Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD. The effects of nuts on coronary heart disease risk. Nutrition Reviews. 59.4 (2001): 103-111. https://doi.org/10.1111/j.1753-4887.2001.tb06996.x

72. Sabaté J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. The American Journal of Clinical Nutrition. 70.3 (1999): 500s-503s.

73. Bao Y, Han J, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS. Association of nut consumption with total and cause-specific mortality. New England Journal of Medicine. 369.21 (2013): 2001-2011. https://doi.org/10.1056/nejmoa1307352

74. Guasch-Ferré M, Bullo M, Martinez-Gonzalez MA, Ros E, Corella D, Estruch R, et al. Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial. BMC Medicine. 11.1 (2013): 1. https://doi.org/10.1186/1741-7015-11-164

75. Craig WJ, Mangels A R. Position of the American Dietetic Association: vegetarian diets. Journal of the American Dietetic Association. 109.7 (2009): 1266-1282. https://doi.org/10.1016/j.jada.2009.05.027

76. Luu HN, Blot WJ, Xiang YB, Cai H, Hargreaves MK, Li H, et al. Prospective evaluation of the association of nut/peanut consumption with total and cause-specific mortality. JAMA Internal Medicine. 175.5 (2015): 755-766. https://doi.org/10.1001/jamainternmed.2014.8347